NeuPath Health Inc. (NPTH.V)
| Previous Close | 0.1700 |
| Open | 0.1700 |
| Bid | 0.1700 x N/A |
| Ask | 0.1700 x N/A |
| Day's Range | 0.1650 - 0.1700 |
| 52 Week Range | 0.1200 - 0.2500 |
| Volume | |
| Avg. Volume | 44,573 |
| Market Cap | 9.57M |
| Beta (5Y Monthly) | 0.79 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | May 23, 2024 - May 27, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Business WireNEUPATH HEALTH TO PRESENT AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE
TORONTO, April 10, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that Joseph Walewicz, CEO, will be presenting at the 2024 Bloom Burton & Co. Healthcare Investor Conference to be held April 16 to 17, 2024 at the Metro Toronto Convention Centre.
Business WireNEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2023 RESULTS
TORONTO, March 15, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three months and year ended December 31, 2023. All figures are in Canadian dollars, unless otherwise noted.
Business WireNEUPATH ANNOUNCES CLINIC ACQUISITION
TORONTO, January 15, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the closing of the acquisition of the assets of SIBI Medical Inc., operating as the London Spine Institute in London, Ontario effective January 12, 2024.
